Results 11 to 20 of about 123,173 (290)

Functional foods and cardiometabolic diseases: International Task Force for Prevention of Cardiometabolic Diseases. [PDF]

Nutrition, metabolism, and cardiovascular diseases : NMCD, 2014
Mounting evidence supports the hypothesis that functional foods containing physiologically-active components may be healthful. Longitudinal cohort studies have shown that some food classes and dietary patterns are beneficial in primary prevention, and ...
Assmann G, Buono P, Daniele A, DELLA VALLE, Elisabetta, FARINARO, EDUARDO, Ferns G, Krogh V, Kromhout D, Masana L, Merino J, Misciagna G, PANICO, SALVATORE, RICCARDI, GABRIELE, RIVELLESE, ANGELA ALBAROSA, ROZZA, FRANCESCO, Salvatore F, Salvatore V, Stranges S, Trevisan M, TRIMARCO, BRUNO, Vetrani C.   +20 more
core   +6 more sources

Cardiometabolic Diseases

JACC: Basic to Translational Science, 2023
Konstantinos Drosatos, MSc, PhD
doaj   +2 more sources

MicroRNAs in Cardiometabolic Diseases [PDF]

The Indonesian Biomedical Journal, 2013
BACKGROUND: MicroRNAs (miRNAs) are ~22-nucleotide noncoding RNAs with critical functions in multiple physiological and pathological processes. An explosion of reports on the discovery and characterization of different miRNA species and their involvement ...
Meiliana, A. (Anna), Wijaya, A. (Andi)
core   +4 more sources

Coronavirus Disease 2019 and Cardiometabolic Disease

Cardiology in Review, 2021
Cardiometabolic disease describes a combination of metabolic abnormalities that increases the risk of type 2 diabetes and cardiovascular diseases, including pathological changes such as insulin resistance, hyperglycemia, dyslipidemia, abdominal obesity, and hypertension, and environmental risk factors such as smoking, sedentary lifestyle, poor diet ...
Chan W, Kim, Wilbert S, Aronow, William H, Frishman   +2 more
openaire   +3 more sources

Circulating Microbiota in Cardiometabolic Disease

Frontiers in Cellular and Infection Microbiology, 2022
The rapid expansion of microbiota research has significantly advanced our understanding of the complex interactions between gut microbiota and cardiovascular, metabolic, and renal system regulation. Low-grade chronic inflammation has long been implicated as one of the key mechanisms underlying cardiometabolic disease risk and progression, even before ...
Keiichi Sumida, Zhongji Han, Chi-Yang Chiu, Tahliyah S. Mims, Amandeep Bajwa, Ryan T. Demmer, Ryan T. Demmer, Susmita Datta, Csaba P. Kovesdy, Csaba P. Kovesdy, Joseph F. Pierre   +10 more
openaire   +3 more sources

Inflammatory markers and cardiometabolic diseases [PDF]

Acta Clinica Belgica, 2015
A growing body of evidence emerges that obesity, metabolic syndrome, type 2 diabetes and cardiovascular disease are intimately related to chronic inflammation.A narrative review summarizing the most recent data of the literature describing the pathological implications of inflammation in obese patients with cardiometabolic disorders.Besides high ...
ESSER, Nathalie, Paquot, Nicolas, Scheen, André   +2 more
openaire   +2 more sources

Uric acid and cardiometabolic diseases [PDF]

Clinical Hypertension, 2020
AbstractHyperuricemia, which has been considered as a cause of gout and nephrolithiasis has recently been suggested to be associated with hypertension, coronary heart disease, heart failure, atrial fibrillation, insulin resistance, and nonalcoholic fatty liver disease.
Seung Jae Lee, Byeong Kil Oh, Ki-Chul Sung   +2 more
openaire   +3 more sources

Calpain and Cardiometabolic Diseases

International Journal of Molecular Sciences, 2023
Calpain is delineated as a superfamily of cysteine proteases containing a CysPC motif within their genes. Among the fifteen species of mammalian homologs, calpain-1 and -2, which are categorized as conventional isozymes, execute limited proteolysis in a calcium-dependent fashion.
openaire   +2 more sources

Alzheimer disease genetic risk factor APOE e4, and cognitive abilities in 111,739 UK Biobank participants [PDF]

, 2016
Background: the apolipoprotein (APOE) e4 locus is a genetic risk factor for dementia. Carriers of the e4 allele may be more vulnerable to conditions that are independent risk factors for cognitive decline, such as cardiometabolic diseases.
Anderson, Jana, Bailey, Mark E.S., Celis, Carlos, Cullen, Breda, Davies, Gail, Deary, Ian J., Evans, Jon, Lyall, Donald M., Mackay, Daniel, McIntosh, Andrew M., Pell, Jill P., Ritchie, Stuart J., Sattar, Naveed, Smith, Daniel J., Ward, Joey   +14 more
core   +1 more source

Dairy consumption and cardiometabolic diseases: systematic review and updated meta-analyses of prospective cohort studies [PDF]

, 2018
Purpose of Review Dairy products contain both beneficial and harmful nutrients in relation to cardiometabolic diseases. Here, we provide the latest scientific evidence regarding the relationship between dairy products and cardiometabolic diseases by ...
A Hruby, A Lamri, A Tremblay, A Tremblay, AG Pittas, B Haring, B Lamarche, BJ Fuhrman, D Aune, D Gao, D Hu, D Kromhout, D Mozaffarian, D Mozaffarian, Daniel Lisko, DD Alexander, DI Givens, Doreen Gille, E Yu, EM Brouwer-Brolsma, F Rosqvist, FP Hartwig, G Buckland, GC Chen, Global Burden of Disease Risk Factors Collaborators, Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration, GW Dalmeijer, HEK Virtanen, HK Bergholdt, HK Bergholdt, HK Choi, I Sluijs, J Bodner-Montville, J Goede de, J Praagman, J Praagman, JA Nettleton, Jing Guo, JJ Dinicolantonio, JM Geleijnse, JP Drouin-Chartier, JP Drouin-Chartier, JP Higgins, JR Benatar, K Ge, KM Turner, L Brink, L Gijsbers, L Pimpin, L Schwingshackl, LA Mierlo van, LET Vissers, LM O'Connor, LQ Qin, M Chen, M Ding, M Kratz, M Talaei, M Talaei, M Talaei, M Talaei, MA Aerde van, MC Oliveira Otto de, ME Labonte, Mendelian Randomization of Dairy Consumption Working Group, MU Jakobsen, N Moslehi, NM Grantham, P Elwood, PC Elwood, Q Liu, Q Yang, R Villegas, S Greenland, S Parvez, Shuang Tian, SR Bauer, SS Lim, SS Soedamah-Muthu, SS Soedamah-Muthu, U Ericson, V Dilis, X Tong   +82 more
core   +3 more sources